Effect of 6-month supervised exercise on low-density lipoprotein apolipoprotein B kinetics in patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 57, Issue 11, 2008, Pages 1608-1614

  Stolinski, Michael ^a   Alam, Saima ^b   Jackson, Nicola C ^a   Shojaee Moradie, Fariba ^a   Pentecost, Claire ^b   Jefferson, William ^b   Christ, Emmanuel R ^c   Jones, Richard H ^b   Umpleby, A Margot ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; EXERCISE; FEMALE; FITNESS; HEMOGLOBIN DETERMINATION; HOMEOSTASIS; HUMAN; INSULIN SENSITIVITY; LIPOPROTEIN METABOLISM; LIPOPROTEIN SYNTHESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; APOLIPOPROTEINS B; BODY MASS INDEX; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; TRIGLYCERIDES;

EID: 53649101063     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.06.018     Document Type: Article

References (34)

1. Krauss R.M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 6 (2004) FS1496-FS1504
2. Heart Prevention Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361 (2003) 2005-2016
3. Austin M.A., Breslow J.L., Hennekens C.H., Buring J.E., Willett W.C., and Krauss R.M. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260 (1988) 1917-1921
4. Berneis K., Jeanneret C., Muser J., Felix B., and Miserez A.R. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism 54 (2005) 227-234
5. Rosenson R.S., Otvos J.D., and Freedman D.S. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 90 (2002) 89-94
6. Packard C.J., and Shepherd J. Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol 17 (1997) 3542-3556
7. Packard C.J. The role of stable isotopes in the investigation of plasma lipoprotein metabolism. Baillieres Clin Endocrinol Metab 9 (1995) 755-772
8. Duvillard L., Pont F., Florentin E., Galland-Jos C., Gambert P., and Verges B. Metabolic abnormalities of apolipoprotein B-containing lipoproteins in non-insulin dependent diabetes: a stable isotope kinetic study. Eur J Clin Invest 30 (2000) 685-694
9. Ronnemaa T., Marniemi J., Puukka P., and Kuusi T. Effects of long-term physical exercise on serum lipids, lipoproteins and lipid metabolizing enzymes in type 2 (non-insulin-dependent) diabetic patients. Diabetes Care 7 (1998) 79-84
10. Honkola A., Forsen T., and Eriksson J. Resistance training improves the metabolic profile in individuals with type 2 diabetes. Acta Diabetologia 34 (1997) 245-248
11. Lehmann R., Vokac A., Niedermann K., Agosti K., and Spinas G.A. Loss of abdominal fat and improvement of the cardiovascular risk profile by regular moderate exercise training in patients with NIDDM. Diabetologia 38 (1995) 1313-1319
12. Alam S., Stolinski M., Pentecost C., Boroujerdi M.A., Jones R.H., Sonksen P.H., et al. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes. J Clin Endocrinol Metab 89 (2004) 688-694
13. In: Roitman J.L. (Ed). ACSM resource manual guidelines. 3rd ed (1998), Williams and Wilkins, Baltimore
14. Borg G.A.V. Borg's perceived exertion and pain scales (1998), Human Kinetics, Champaign (Ill)
15. Matthews D.E., Schwarz H.P., Yang R.D., Motil K.J., Young V.R., and Bier D.M. Relationship of plasma leucine and -ketoisocaproate during a l-[1-13C]leucine infusion in man: a method for measuring human intracellular leucine tracer environment. Metab Clin Exper 31 (1982) 1105-1112
16. Cummings M.H., Watts G.F., Umpleby M., Hennessy T.R., Quiney J.R., and Sonksen P.H. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study. Atherosclerosis 113 (1995) 79-89
17. Christ E.R., Cummings M.H., Jackson N., Stolinski M., Lumb P.J., Wierzbicki A.S., et al. Effects of growth hormone (GH) replacement therapy on low-density lipoprotein apolipoprotein B100 kinetics in adult patients with GH deficiency: a stable isotope study. J Clin Endocrinol Metab 89 (2004) 1801-1807
18. Cummings M.H., Watts G.F., Lumb P.J., and Slavin B.M. Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B100 in plasma. J Clin Pathol. 47 (1994) 176-178
19. Cohn J.S., Wagner D.A., Cohn S.D., Millar J.S., and Schaefer E.J. Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest 85 (1990) 804-811
20. Pearson T.C., Guthrie D.L., Simpson J., Chinn S., Barosi G., Ferrant A., et al. Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol 89 (1995) 748-756
21. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
22. Duvillard L., Pont F., Florentin E., Gambert P., and Verges B. Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus. Diabetologia 43 (2000) 27-35
23. Lee W., Min W.-K., Chun S., Jang S., Kim J.Q., Lee D.H., et al. Low-density lipoprotein subclass and its correlating factors in diabetes. Clin Biochem 36 (2003) 657-661
24. Pietzsch J., Lattke P., and Julius U. Oxidation of apolipoprotein B-100 in circulating LDL is related to LDL residence time. In vivo insights from stable isotope studies. Arterioscler Thromb Vasc Biol 20 (2000) E63-E67
25. Rizzo M., and Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJMed 99 (2006) 1-14
26. Wagner A.M., Jorba O., Rigla M., de Leiva A., Ordonez-Llanos J., and Perez A. Effect of improving glycemic control on low-density lipoprotein particle size in type 2 diabetes. Metabolism 52 (2003) 1576-1578
27. Rigla M., Sanchez-Quesada J.L., Ordonez-Llanos J., Prat T., Caixas A., Jorba O., et al. Effect of physical exercise on lipoprotein(a) and low-density lipoprotein modifications in type 1 and type 2 diabetic patients. Metabolism 49 (2000) 640-647
28. Lund-Katz S., Laplaud P.M., Phillips M.C., and Chapman M.J. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction. Biochemistry 37 (1998) 12867-12874
29. Lahdenpera S., Sane T., Vuorinen-Markkola H., Knudsen P., and Taskinen M.R. LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes. Atherosclerosis 113 (1995) 227-236
30. Stewart M.W., Laker M.F., Dyer R.G., Game F., Mitcheson J., Winocour P.H., et al. Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia. Arterioscler Thromb. 13 (1993) 1046-1052
31. Packard C.J. Triacylglycerol-rich lipoproteins and the generation of small, dense low density lipoprotein. Biochemistry Society Transactions 31 Pt 5 (2003) 1066-1069
32. Griffin B.A., Freeman D.J., Tait G.W., Thomson J., Caslake M.J., Packard C.J., et al. Role of plasma TG in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106 (1994) 241-253
33. Tan K.C.B., Cooper M.B., Eddie Ling K.L., Griffin B.A., Freeman D.J., Packard C.J., et al. Fasting and postprandial determinants for the occurrence of small dense LDL species in non-insulin dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 113 (1995) 273-287
34. Ng T.W., Watts G.F., Barrett P.H., Rye K.A., and Chan D.C. Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care. 30 (2007) 2945-2950